As an example, Canfosfamide (TLK286, TELCYTA®), a cancer cell-activated prodrug, was designed to exploit the elevated levels and the activity of glutathione S-transferase P1-1 (GSTP1-1) that is overexpressed in many human cancer cells (Tew, 2005). Here, GSTP1 is linked to cancer.